反应详情

温度

0 °C

A solution of 2-[3-(3-chlorophenyl)-7-methoxy-1-oxo-1H-isoquinolin-2-yl]-N-isopropylacetamide (886 mg, 2.30 mmol) in dry DCM (25 mL) was cooled to −78° C. and a solution of BBr3 (1 M in DCM, 20.3 mL, 20.3 mmol) was added dropwise. After 1 h, the cooling bath was removed and the mixture was allowed to stir an additional 17.5 h, then cooled to 0° C. and quenched by dropwise addition of sat. NaHCO3 (aq.) (15 mL). The aqueous mixture was extracted with IPA:DCM (1:3, v/v) (4×25 mL). The combined organic extracts were washed with brine (25 mL), dried (MgSO4) and concentrated to give the crude product, which was recrystallized from EtOH to give pure 2-[3-(3-chlorophenyl)-7-hydroxy-1-oxo-1H-isoquinolin-2-yl]-N-isopropylacetamide (INTERMEDIATE III.7) (530 mg, 1.43 mmol, 62%) as white solid.

1. customthe cooling bath was removed
2. customquenched by dropwise addition of sat. NaHCO3 (aq.) (15 mL)
3. extractionThe aqueous mixture was extracted with IPA:DCM (1:3
4. washThe combined organic extracts were washed with brine (25 mL)
5. dry with materialdried (MgSO4)
6. concentrationconcentrated
7. customto give the crude product, which
8. customwas recrystallized from EtOH